XML 58 R65.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 13 - Share-Based Compensation (Detail) (USD $)
12 Months Ended 12 Months Ended 24 Months Ended 12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2003
Dec. 31, 1993
Dec. 31, 2012
Director [Member]
Dec. 31, 2012
Stock Appreciation Rights (SARs) [Member]
Dec. 31, 2011
Stock Appreciation Rights (SARs) [Member]
Dec. 31, 2012
Stock Appreciation Rights (SARs) [Member]
Dec. 31, 2010
Stock Appreciation Rights (SARs) [Member]
Dec. 31, 2012
Common Stock [Member]
Dec. 31, 2011
Common Stock [Member]
Dec. 31, 2012
Available to Issue
Dec. 31, 2011
Available to Issue
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in Shares)         1,500,000                  
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in Shares)       2,500,000                    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 5 years         10 years     5 years [1]          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value $ 444,000           $ 64,000   $ 64,000          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Total Intrinsic Value 269,000 256,000         122,000 5,000            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share) $ 3.38 $ 2.97         $ 3.59 $ 2.96            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in Shares) 138,252 117,846         (134,304) (2,100)     138,252 117,846    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares) 614,917 671,500 699,790       176,476 257,424 176,476 207,380     1,284,675 1,419,700
Allocated Share-based Compensation Expense 893,000 1,005,000                        
Deferred Other Tax Expense (Benefit) (96,000) (145,000)                        
Proceeds from Stock Options Exercised 889,000 958,000                        
Tax Benefit from Stock Options Exercised $ 60,000 $ 55,000                        
Stock Repurchased During Period, Shares (in Shares) 34,073 8,491                 34,073 8,491    
Shares, Issued (in Shares) 41,596 10,900                        
[1] The expected life in years for awards granted was based on the historical exercise patterns experienced by the Company when the award is made.